Renal issues in HIV infection (Q37885232)

24 August 2017

1 reference

title

Renal issues in HIV infection (English)

1 reference

24 August 2017

Robert C Kalayjian

1

1 reference

24 August 2017

1 September 2011

1 reference

24 August 2017

Current HIV/AIDS reports

1 reference

24 August 2017

8

1 reference

24 August 2017

164-171

1 reference

24 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-011-0080-x

24 August 2017

0 references

cites work

The impact of HIV on chronic kidney disease outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Kidney function and the risk of cardiovascular events in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Hepatitis C and the risk of kidney disease and mortality in veterans with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Antiretroviral therapy improves renal function among HIV-infected Ugandans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Renal disease in an antiretroviral-naïve HIV-infected outpatient population in Western Kenya.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Chronic renal failure among HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Association between coronary artery calcification progression and microalbuminuria: the MESA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Microalbuminuria and risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

The relationship between proteinuria and coronary risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Early expression of zona pellucida proteins under octylphenol exposure in Cichlasoma dimerus (Perciformes, Cichlidae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

The role of HIV in serious diseases other than AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

HIV viremia and changes in kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Tenofovir-associated decline in renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Renal function with use of a tenofovir-containing initial antiretroviral regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

The impact of gender and anchor drugs on TDF renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Outcomes of kidney transplantation in HIV-infected recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0080-X

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

21 January 2018

1 reference

12 December 2020

Dialysis and Renal Transplantation in HIV-Infected Patients: a European Survey

1 reference

12 December 2020

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

12 December 2020

Observations on a cohort of HIV-infected patients undergoing native renal biopsy

1 reference

12 December 2020

Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies

1 reference

12 December 2020

Factors associated with decreased kidney function in HIV-infected adults enrolled in the MTCT-Plus Initiative in sub-Saharan Africa

1 reference

12 December 2020

10.1007/S11904-011-0080-X

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21643783